Yew Bio-Pharm Group, Inc. Total Assets
Yew Bio-Pharm Group, Inc. had Total Assets of $61.40 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2021-11-15
- 2021-09-30: Assets $61.40M.
- 2021-06-30: Assets $63.25M.
- 2021-03-31: Assets $61.93M.
- 2020-12-31: Assets $58.45M.
| Period end | Assets |
|---|---|
| 2021-09-30 | $61.40M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $63.25M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $61.93M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $58.45M 10-Q · filed 2021-11-15 |
| 2020-09-30 | $56.67M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $55.74M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $52.81M 10-Q · filed 2020-06-29 |
| 2019-12-31 | $54.21M 10-K · filed 2021-03-30 |
| 2019-09-30 | $54.29M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $58.51M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $53.46M 10-Q · filed 2019-05-22 |
| 2018-12-31 | $49.69M 10-K · filed 2020-05-14 |
| 2018-09-30 | $55.23M 10-Q · filed 2018-11-19 |
| 2018-06-30 | $53.36M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $54.47M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $52.93M 10-K · filed 2019-05-07 |
| 2017-09-30 | $59.86M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $59.19M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $47.60M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $46.20M 10-K · filed 2018-04-02 |
| 2016-09-30 | $48.62M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $45.57M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $45.27M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $43.81M 10-K · filed 2017-03-31 |
| 2015-09-30 | $43.23M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $41.92M 10-Q · filed 2015-08-18 |
| 2015-03-31 | $37.87M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $35.04M 10-K · filed 2016-03-30 |
| 2014-09-30 | $34.56M 10-Q · filed 2014-11-17 |
| 2014-06-30 | $34.11M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $34.99M 10-Q · filed 2014-05-20 |
| 2013-12-31 | $35.31M 10-K · filed 2015-03-31 |
| 2013-09-30 | $31.60M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $30.90M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $29.27M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $28.04M 10-K · filed 2014-03-31 |
| 2012-09-30 | $27.66M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $26.23M 10-Q/A · filed 2012-09-14 |
| 2011-12-31 | $24.90M 10-K · filed 2013-04-11 |